Aromasin (exemestane)

DRUG3 trials

Sponsors

Pfizer

Conditions

Breast NeoplasmsEarly Breast CancerPost Menopausal Women With Early Breast Cancer

Phase 4

Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

CompletedNCT01176916

PfizerBreast Neoplasms

Start: 2011-02-09End: 2018-11-30Updated: 2021-10-27

Unknown Phase

Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)

CompletedNCT01050634

PfizerPost Menopausal Women With Early Breast Cancer

Start: 2005-11-30End: 2009-04-30Updated: 2010-07-23

Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients

TerminatedNCT01155063

PfizerEarly Breast Cancer

Start: 2010-09-30End: 2011-09-30Updated: 2012-10-01